Table 4. Logistic Regression Analysis of Potential Factors Influencing the Clinical or Endoscopic Prognosis of ITIUs .
| Factor | Clinical Outcome | Endoscopic Outcome | ||||
| Hazard Ratio | 95% Ci | P | Hazard Ratio | 95% CI | P | |
| Gender | ||||||
| Female | 1.000 | 1.000 | ||||
| Male | 0.776 | 0.000 | 1.000 | 2.013 | 0.061-66.034 | |
| Age | 2.968 | 0.000 | 0.998 | 0.972 | 0.862-1.097 | |
| Chief complaint | ||||||
| Health examination | 1.000 | 1.000 | ||||
| Abdominal pain | 9.446 | 0.000 | 1.000 | 1.863 | 0.000 | 1.000 |
| Diarrhea | 565.732 | 0.000 | 1.000 | 0.000 | 0.000 | 0.999 |
| Constipation | 3137853.19 | 0.000 | 0.999 | 0.000 | 0.000 | 0.999 |
| Hematochezia | 0.000 | 0.000 | 0.999 | 0.000 | 0.000 | 0.999 |
| Others* | 0.000 | 0.000 | 0.999 | 0.566 | 0.000 | 1.000 |
| Number of ulcers | 0.670 | |||||
| Single | 1.000 | 1.000 | ||||
| Multiple | 9.079 | 0.000 | 1.000 | 2.321 | 0.048-111.971 | |
| Treatment | 0.454 | |||||
| Observational follow-up | 1.000 | 1.000 | ||||
| Empiric therapy# | 0.000 | 0.000 | 0.999 | 3.169 | 0.154-65.040 | |
*Other complaints include abdominal discomfort or distension, dyspepsia, weight loss, anemia, fever, and other non-intestinal disorders.
#Empiric therapy includes 5-ASA, probiotics, and 5-ASA plus probiotics.